“Epigenome-wide methylation profile of chronic kidney disease-derived arterial DNA uncovers novel pathways in disease-associated cardiovascular pathology.”

References

• Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305.
   Google Scholar
• Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38(4):938–942.
   Google Scholar
• Briet M, Burns KD. Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications. Clin Sci (Lond). 2012;123(7):399–416.
   Google Scholar
• London GM, Safar ME, Pannier B. Aortic aging in ESRD: structural, hemodynamic, and mortality implications. J Am Soc Nephrol. 2016;27(6):1837–1846.
   Google Scholar
• Hamczyk MR, Nevado RM, Barettino A, et al. Biological versus chronological aging: JACC focus seminar. J Am Coll Cardiol. 2020;75(8):919–930.
   Google Scholar
• Zawada AM, Rogacev KS, Heine GH. Clinical relevance of epigenetic dysregulation in chronic kidney disease-associated cardiovascular disease. Nephrol Dialysis Transplantation. 2013;28(7):1663–1671.
   Google Scholar
• Schübeler D. Function and information content of DNA methylation. Nature. 2015;517(7534):321–326.
   Google Scholar
• Bell CG, Beck S. The epigenomic interface between genome and environment in common complex diseases. Brief Funct Genomics. 2010;9(5–6):477–485.
   Google Scholar
• Smyth LJ, McKay GJ, Maxwell AP, et al. DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease. Epigenetics. 2014;9(3):366–376.
   Google Scholar
• Ko YA, Mohtat D, Suzuki M, et al. Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol. 2013;14(10):R108.
   Google Scholar
• Chu AY, Tin A, Schlosser P, et al. Epigenome-wide association studies identify DNA methylation associated with kidney function. Nat Commun. 2017;8(1):1286.
   Google Scholar
• Wing MR, Devaney JM, Joffe MM, et al. DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study. Nephrol Dial Transplant. 2014;29(4):864–872.
   Google Scholar
• Sapienza C, Lee J, Powell J, et al. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics. 2011;6(1):20–28.
   Google Scholar
• Lecamwasam A, Sexton-Oates A, Carmody J, et al. DNA methylation profiling of genomic DNA isolated from urine in diabetic chronic kidney disease: a pilot study. PLoS One. 2018;13(2):e0190280.
   Google Scholar
• Schultz MD, He Y, Whitaker JW, et al. Human body epigenome maps reveal noncanonical DNA methylation variation. Nature. 2015;523(7559):212–216.
   Google Scholar
• Mansell G, Gorrie-Stone TJ, Bao Y, et al. Guidance for DNA methylation studies: statistical insights from the Illumina EPIC array. BMC Genomics. 2019;20(1):366.
   Google Scholar
• Irizarry RA, Ladd-Acosta C, Wen B, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009;41(2):178–186.
   Google Scholar
• Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.
   Google Scholar
• Zhou Q, Liao JK. Rho kinase: an important mediator of atherosclerosis and vascular disease. Curr Pharm Des. 2009;15(27):3108–3115.
   Google Scholar
• Duluc L, Wojciak-Stothard B. Rho GTPases in the regulation of pulmonary vascular barrier function. Cell Tissue Res. 2014;355(3):675–685.
   Google Scholar
• Fani L, van der Willik KD, Bos D, et al. The association of innate and adaptive immunity, subclinical atherosclerosis, and cardiovascular disease in the rotterdam study: a prospective cohort study. PLoS Med. 2020;17(5):e1003115.
   Google Scholar
• Zheng SC, Webster AP, Dong D, et al. A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix. Epigenomics. 2018;10(7):925–940.
   Google Scholar
• Kachgal S, Mace KA, Boudreau NJ. The dual roles of homeobox genes in vascularization and wound healing. Cell Adh Migr. 2012;6(6):457–470.
   Google Scholar
• Dunn J, Qiu H, Kim S, et al. Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis. J Clin Invest. 2014;124(7):3187–3199.
   Google Scholar
• Kulis M, Heath S, Bibikova M, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet. 2012;44(11):1236–1242.
   Google Scholar
• Spainhour JC, Lim HS, Yi SV, et al. Correlation patterns between DNA methylation and gene expression in the cancer genome atlas. Cancer Inform. 2019;18:1176935119828776.
   Google Scholar
• Jones A, Teschendorff AE, Li Q, et al. Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development. PLoS Med. 2013;10(11):e1001551.
   Google Scholar
• Bell CG, Lowe R, Adams PD, et al. DNA methylation aging clocks: challenges and recommendations. Genome Biol. 2019;20(1):249.
   Google Scholar
• Chen J, Huang Y, Hui Q, et al. Epigenetic associations with estimated glomerular filtration rate (eGFR) among men with HIV infection. Clin Infect Dis. 2020;70(4):667–673.
   Google Scholar
• Andrews SV, Ladd-Acosta C, Feinberg AP, et al. “Gap hunting” to characterize clustered probe signals in Illumina methylation array data. Epigenetics Chromatin. 2016;9(1):56.
   Google Scholar
• Pidsley R, Zotenko E, Peters TJ, et al. Critical evaluation of the illumina methylationEPIC beadchip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016;17(1):208.
   Google Scholar
• Morris TJ, Butcher LM, Feber A, et al. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics. 2014;30(3):428–430.
   Google Scholar
• Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylationmicroarrays. Bioinformatics. 2014;30(10):1363–1369.
   Google Scholar
• Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of infinium DNA methylation BeadChip probes. Nucleic Acids Res. 2017;45(4):e22.
   Google Scholar
• Nordlund J, Backlin CL, Wahlberg P, et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 2013;14(9):r105.
   Google Scholar
• Teschendorff AE, Marabita F, Lechner M, et al. A beta-mixture quantile normalization method for correcting probe design bias in illumina infinium 450 k DNA methylation data. Bioinformatics. 2013;29(2):189–196.
   Google Scholar
• Teschendorff AE, Menon U, Gentry-Maharaj A, et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One. 2009;4(12):e8274.
   Google Scholar
• Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118–127.
   Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
   Google Scholar
• Jaffe AE, Murakami P, Lee H, et al. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol. 2012;41(1):200–209.
   Google Scholar
• Phipson B, Maksimovic J, Oshlack A. missMethyl: an R package for analyzing data from Illumina’s HumanMethylation450 platform. Bioinformatics. 2016;32(2):286–288.
   Google Scholar
• Cavalcante RG, Sartor MA. annotatr: genomic regions in context. Bioinformatics. 2017;33(15):2381–2383.
   Google Scholar
• Graw S, Henn R, Thompson JA, et al. pwrEWAS: a user-friendly tool for comprehensive power estimation for epigenome wide association studies (EWAS). BMC Bioinformatics. 2019;20(1):218.
   Google Scholar